BPA CALL
Active36C24827N0014
Department of Veterans Affairs › 248-NETWORK CONTRACT OFFICE 8 (36C248)
$1.5M
obligated · signed 6 days ago
GA-68 GOZETOTIDE - ILLUCCIX
Performance timeline
Start
Oct 1, 2026
End
Sep 30, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 30, 2027
TELIX PHARMACEUTICALS US INC
Contract 36C24827N0014
UEI
NMRHMBK4YTH7
Parent Company
TELIX PHARMACEUTICALS US INC
Capabilities & Certifications
Headquarters Location
Congressional District: 05
Current Obligation
$1,500,000
Base + Exercised Options
$1,500,000
Total Ceiling Value
$1,500,000
Contract Type
FIRM FIXED PRICE
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 05
Awarding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
248-NETWORK CONTRACT OFFICE 8 (36C248)
Office
Funding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
248-NETWORK CONTRACT OFFICE 8 (36C248)
Office
Contract Vehicle
36E79722A0025
BPADepartment of Veterans Affairs
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.